The tumour-associated microbiome
- PMID: 35361914
- PMCID: PMC10790629
- DOI: 10.1038/s41575-022-00609-7
The tumour-associated microbiome
Abstract
The burgeoning field of intratumoural microbiome research has been driven by advances in next-generation sequencing technologies, with compelling evidence on the role of the microbiota in cancer initiation, progression and patient response to treatment. Here, we discuss new concepts of the tumour-associated microbiota and what is needed to advance the translational impact of these findings in gastrointestinal cancers.
Conflict of interest statement
Competing interests
C.D.J. has consulted for Seres Therapeutics and Azitra. S.B. has consulted for GlaxoSmithKline and BioMx; and is on the cancer programme advisory board for BioMx.
Figures
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
